Natural IgG Anti-F (ab')2 Autoantibody Activity in Children with Autism

Background: Many and diverse autoimmune abnormalities have been reported in children with autism. Natural autoantibodies (NAAbs) play important immunoregulatory roles in recognition of the immune self. The objective of this study was to examine the presence of NAAbs in the sera of children with autism and across severity subgroups of autistic behavioral impairments. Methods: NAAbs were titrated in sera through an ELISA procedure in 60 low-functioning children with autism and 112 typically developing controls matched for age, sex and puberty. Results: Serum titers of IgG anti-F(ab')(2) autoantibodies were significantly lower in children with autism compared to typically developing controls (p < 0.0001), and were significantly negatively associated with autism severity (p = 0.0001). This data appears to be related more specifically to autism than to intellectual disability, given that IgG anti-F(ab')(2) levels were significantly negatively correlated with IQ scores in the autism group (p = 0.01). Conclusions: This is the first report in autism of abnormally low natural anti-F(ab')(2) autoantibody activity. The findings suggest a dysfunction of self-recognition mechanisms which may play a role in the pathogenesis of autism, especially for the severely affected children. These findings strengthen the hypothesis of an autoimmune process in autism and open the prospect of alternative medical treatment. Further neuroimmunological research is warranted to understand the exact mechanisms underlying this reduced natural IgG anti-F (ab')(2) autoantibody activity, and to assess its impact on the pathophysiology and behavioral expression of autism.

Automated summary

This study examined the presence of natural autoantibodies (NAAbs) in the sera of children with autism and found significantly lower levels of IgG anti-F(ab')(2) autoantibodies compared to typically developing controls. These levels were negatively associated with autism severity and IQ scores in the autism group. These findings strengthen the hypothesis of an autoimmune process in autism and suggest the potential for alternative medical treatment.